Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.
Publication
, Journal Article
Meredith, PA; Ostergren, J; Anand, I; Puu, M; Solomon, SD; Michelson, EL; Olofsson, B; Granger, CB; Yusuf, S; Swedberg, K; Pfeffer, MA; McMurray, JJV
Published in: J Am Coll Cardiol
December 9, 2008
OBJECTIVES: This study sought to investigate the efficacy and tolerability of candesartan, according to baseline blood pressure (BP), in the 4,576 patients with a low ejection fraction (EF) (
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
December 9, 2008
Volume
52
Issue
24
Start / End Page
2000 / 2007
Location
United States
Related Subject Headings
- Ventricular Function, Left
- Treatment Outcome
- Time Factors
- Tetrazoles
- Systole
- Stroke Volume
- Risk Factors
- Retrospective Studies
- Prognosis
- Middle Aged
Citation
APA
Chicago
ICMJE
MLA
NLM
Meredith, P. A., Ostergren, J., Anand, I., Puu, M., Solomon, S. D., Michelson, E. L., … McMurray, J. J. V. (2008). Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program. J Am Coll Cardiol, 52(24), 2000–2007. https://doi.org/10.1016/j.jacc.2008.09.011
Meredith, Peter A., Jan Ostergren, Inder Anand, Margareta Puu, Scott D. Solomon, Eric L. Michelson, Bertil Olofsson, et al. “Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.” J Am Coll Cardiol 52, no. 24 (December 9, 2008): 2000–2007. https://doi.org/10.1016/j.jacc.2008.09.011.
Meredith PA, Ostergren J, Anand I, Puu M, Solomon SD, Michelson EL, et al. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program. J Am Coll Cardiol. 2008 Dec 9;52(24):2000–7.
Meredith, Peter A., et al. “Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program.” J Am Coll Cardiol, vol. 52, no. 24, Dec. 2008, pp. 2000–07. Pubmed, doi:10.1016/j.jacc.2008.09.011.
Meredith PA, Ostergren J, Anand I, Puu M, Solomon SD, Michelson EL, Olofsson B, Granger CB, Yusuf S, Swedberg K, Pfeffer MA, McMurray JJV. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) Program. J Am Coll Cardiol. 2008 Dec 9;52(24):2000–2007.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
December 9, 2008
Volume
52
Issue
24
Start / End Page
2000 / 2007
Location
United States
Related Subject Headings
- Ventricular Function, Left
- Treatment Outcome
- Time Factors
- Tetrazoles
- Systole
- Stroke Volume
- Risk Factors
- Retrospective Studies
- Prognosis
- Middle Aged